Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N33-26 |
filingDate |
2008-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aeab27ede3116111a3dc9e057e5c375 |
publicationDate |
2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-101662937-B |
titleOfInvention |
cancer treatment |
abstract |
The present invention relates to methods of treating cancer and precancerous syndromes in a mammal (including a human) in need thereof comprising administering to the mammal a therapeutically effective amount of a non-peptide TPO receptor agonist. |
priorityDate |
2007-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |